FINWIRES · TerminalLIVE
FINWIRES

Revolve Growing Its Distributed Generation Portfolio with Definitive Agreements for 9 New Solar Projects in Mexico

-- Revolve Renewable Power (REVV.CN), a North American owner, operator and developer of renewable energy projects, announced Wednesday the continued expansion of its distributed power solutions business with the signing of definitive agreements for a new portfolio of nine solar projects in Mexico with a total capacity of 2.4 megawatts.

In a statement, it said the portfolio will be added to the 6.05 MW of operating assets Revolve currently owns in Mexico and the 2.8 MW (16 projects) under construction in partnership with RER Energy, as announced on March 5, 2026.

The new portfolio is expected to generate annual revenue in the range of US$370,000 to $843,000, with annual EBITDA estimated in the range of $296,000 to $676,000, from the sale of electricity to the commercial customer, it added.

"This latest portfolio of projects is representative of the accelerated growth we are seeing in the distributed generation sector in Mexico," said CEO Myke Clark. "This manufacturing customer will see long-term savings on their electricity bill and a reduction in their operating costs. For Revolve, we are expanding our portfolio of revenue-generating assets underpinned by stable, 20-year power purchase agreements. The distributed generation opportunity in Mexico remains substantial, and we are only beginning to capture it. Our growing pipeline and scalable project model give us significant runway for continued growth in this market. Equally important, the expertise and platform we have built position us to extend our distribution generation strategy into other jurisdictions, including the United States."

The company has also commenced construction on a separate, independent 490 kW distributed generation solar project for a commercial customer in Irapuato, Mexico. Construction on the 490 kW project is expected to be completed by the end of May 2026.

Shares in REVV were unchanged at $0.175 on the CSE yesterday.

Related Articles

Asia

American Tungsten & Antimony Joins US Defense Supply Chain Consortium; Shares Up 12%

American Tungsten & Antimony (ASX:AT4) has joined the US Defense Industrial Base Consortium (DIBC), gaining access to US defense programs and advancing its antimony and tungsten strategy amid a growing focus on secure domestic critical mineral supply chains, according to a Friday Australian bourse filing.The company, through the consortium, gains access to Department of War programs, funding opportunities, and defense partnerships to advance domestic processing and strengthen supply chains in line with national security priorities, per the filing.The company also stated that over 50 DIBC-related projects have already secured about $410 million in funding, including roughly $39 million this year, highlighting strong government support, the filing said.The company will host a government-level critical minerals event in Utah on May 15, bringing together senior US officials, state leaders, and industry stakeholders, the filing added.The company's shares rose 12% in recent Friday trade.

$ASX:AT4
Asia

EBR Systems Receives Priority Review Determination From Therapeutic Goods Administration; Shares Up 7%

EBR Systems (ASX:EBR) received priority review determination from the Therapeutic Goods Administration for the WiSE System, according to a Friday filing with the Australian bourse.The WiSE System is a cardiac device capable of pacing the heart without a lead.The determination provides an accelerated pathway for the device to be included on the Australian Register of Therapeutic Goods, the filing said.Shares rose 7% in morning trade on Friday.

$ASX:EBR
Asia

Star Sports Medicine Launches Up to HK$830 Million Hong Kong IPO

Star Sports Medicine (HKG:1609) launched its Hong Kong initial public offering on Friday, seeking to raise about HK$829.6 million from the deal.The China-based medical device company is offering 8.4 million H-shares at an offer price of HK$98.50 per share, according to a Hong Kong bourse filing.The offering comprises 842,200 shares for Hong Kong investors and 7.6 million shares for international investors, subject to reallocation.The Hong Kong public offering closes on April 29, with allocation results due by May 4, ahead of the company's planned trading debut on May 5.Net proceeds will be used mainly to expand production capacity and enhance manufacturing efficiency, as well as support research and development.The funds will also be used to strengthen sales and marketing capabilities, expand global distribution, and for working capital and general corporate purposes.CITIC Securities (Hong Kong) and CCB International Capital are acting as joint sponsors.CLSA and CCB International Capital are serving as overall coordinators, alongside China Galaxy International Securities and CMBC Securities, and are also acting as joint bookrunners.Futu Securities International (Hong Kong), Open Securities, Orient Securities (Hong Kong), and Zheshang International Financial are acting as joint bookrunners and joint lead managers.

$HKG:1609